Advisor Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $121K | Hold |
1,057
| – | – | ﹤0.01% | 2791 |
|
|
2019
Q3 | $85K | Buy |
1,057
+2
| +0.2% | +$161 | ﹤0.01% | 3004 |
|
|
2019
Q2 | $77K | Sell |
1,055
-12
| -1% | -$876 | ﹤0.01% | 3055 |
|
|
2019
Q1 | $100K | Buy |
1,067
+412
| +63% | +$38.6K | ﹤0.01% | 2854 |
|
|
2018
Q4 | $48K | Sell |
655
-21
| -3% | -$1.54K | ﹤0.01% | 3205 |
|
|
2018
Q3 | $59K | Sell |
676
-296
| -30% | -$25.8K | ﹤0.01% | 3151 |
|
|
2018
Q2 | $96K | Buy |
972
+207
| +27% | +$20.4K | ﹤0.01% | 2553 |
|
|
2018
Q1 | $92K | Buy |
765
+460
| +151% | +$55.3K | ﹤0.01% | 2613 |
|
|
2017
Q4 | $39K | Buy |
305
+185
| +154% | +$23.7K | ﹤0.01% | 3250 |
|
|
2017
Q3 | $15K | Sell |
120
-57
| -32% | -$7.13K | ﹤0.01% | 3718 |
|
|
2017
Q2 | $14K | Buy |
177
+50
| +39% | +$3.96K | ﹤0.01% | 3717 |
|
|
2017
Q1 | $6K | Sell |
127
-17
| -12% | -$803 | ﹤0.01% | 4011 |
|
|
2016
Q4 | $5K | Sell |
144
-54
| -27% | -$1.88K | ﹤0.01% | 3907 |
|
|
2016
Q3 | $13K | Buy |
198
+9
| +5% | +$591 | ﹤0.01% | 3396 |
|
|
2016
Q2 | $7K | Buy |
+189
| New | +$7K | ﹤0.01% | 3621 |
|